Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Lymphatic Malformations
NCT01290484Phase 2Completed
- Sponsor
- Stanford University
- Start
- Dec 2010
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ASP-001 in Lymphatic Malformation (LM), sponsored by Stanford University. Primary endpoint: Change in Volume of Lymphatic Malformation at 20 weeks. Started Dec 2010; status: completed.
02
Drugs
ASP-001
03
Conditions
Lymphatic Malformation (LM)
Beyond the preview
Go deeper on NCT01290484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01290484.